Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
Introduction: Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) present with a range of symptoms including post-exertional malaise (PEM), orthostatic intolerance, and autonomic dysfunction. Dysfunction of the blood vessel endothelium could be an underlying biological mechanis...
Main Authors: | Kari Sørland, Miriam Kristine Sandvik, Ingrid Gurvin Rekeland, Lis Ribu, Milada Cvancarova Småstuen, Olav Mella, Øystein Fluge |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.642710/full |
Similar Items
-
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
by: Ingrid G. Rekeland, et al.
Published: (2020-04-01) -
Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases
by: Barbara B. Comerford, et al.
Published: (2019-07-01) -
Predicting GP visits: A multinomial logistic regression investigating GP visits amongst a cohort of UK patients living with Myalgic encephalomyelitis
by: R. Stephen Walsh, et al.
Published: (2020-06-01) -
A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
by: S. Du Preez, et al.
Published: (2018-12-01) -
An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
by: Keng Ngee Hng, et al.
Published: (2021-08-01)